WMSA
RGLS

Weiss Multi-Strategy Advisers’s Regulus Therapeutics RGLS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-500
Closed -$410K – 517
2014
Q3 		$410K Sell
500
-83
-14% -$70.2K 0.01% 448
2014
Q2 		$563K Hold
583
– – 0.01% 503
2014
Q1 		$631K Buy
583
+416
+249% +$461K 0.01% 583
2013
Q4 		$148K Buy
+167
New +$144K ﹤0.01% 927

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RGLS Position: Q4 2014 in Review

Weiss Multi-Strategy Advisers sold out of Regulus Therapeutics (RGLS) in Q4 2014, closing a stake of 500 shares — an estimated $410K sold.

Weiss Multi-Strategy Advisers first reported a position in RGLS in Q4 2013 and held it in 4 quarters. The position peaked at $631K in Q1 2014. 83 funds tracked by Wall St. Rank hold RGLS as of Q4 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Regulus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 500 Regulus Therapeutics shares in Q4 2014, an estimated $410K.
  • Weiss Multi-Strategy Advisers first reported a position in Regulus Therapeutics in Q4 2013 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Regulus Therapeutics position peaked at $631K in Q1 2014.
  • 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.